WGS Insider Trading Activity and SEC Form 4 Filings
WGS insider trading summary
Over the past 12 months, insiders at GeneDx Holdings Corp. (WGS) reported 89 sales worth $17.3M by 4 insiders and 70 open-market purchases worth $233.9M by 6 insiders on SEC Form 4. Net insider buying was $216.6M.
Latest WGS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 16, 2026 | Katherine Stueland | Chief Executive Officer | Sell | $407K (4,141 @ $98.27) |
| Sep 16, 2026 | Katherine Stueland | Chief Executive Officer | Sell | $14K (148 @ $95.41) |
| Sep 16, 2026 | Katherine Stueland | Chief Executive Officer | Sell | $148K (1,525 @ $96.90) |
| Sep 16, 2026 | Kevin Feeley | Chief Financial Officer | Sell | $52K (541 @ $96.90) |
| Sep 16, 2026 | Katherine Stueland | Chief Executive Officer | Sell | $155K (1,648 @ $94.26) |
| Sep 16, 2026 | Kevin Feeley | Chief Financial Officer | Sell | $107K (1,079 @ $99.00) |
| Sep 16, 2026 | Kevin Feeley | Chief Financial Officer | Sell | $55K (586 @ $94.26) |
| Sep 16, 2026 | Kevin Feeley | Chief Financial Officer | Sell | $144K (1,470 @ $98.27) |
| Sep 16, 2026 | Kevin Feeley | Chief Financial Officer | Sell | $5K (52 @ $95.41) |
| Sep 16, 2026 | Katherine Stueland | Chief Executive Officer | Sell | $301K (3,039 @ $99.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.